187 results about "Polyanhydrides" patented technology

The present invention is directed to disposable composite downhole tool formed of a resin-coated fiber. The fiber is formed of a degradable polymer, such as a poly(lactide) or polyanhydride. The resin is formed of the same degradable polymer as the fiber. It chemically bonds to the fiber, thereby making a strong rigid structure once cured. The fiber may be formed into a fabric before being coated with the resin. Alternatively, the fiber is formed of a non-biodegradable material.

The present invention is directed to disposable composite downhole tool formed of a resin-coated fiber. The fiber is formed of a degradable polymer, such as a poly(lactide) or polyanhydride. The resin is formed of the same degradable polymer as the fiber. It chemically bonds to the fiber, thereby making a strong rigid structure once cured. The fiber may be formed into a fabric before being coated with the resin. Alternatively, the fiber is formed of a non-biodegradable material.

The present invention is directed to microparticles, to microparticle compositions containing the same, to methods of forming the same, and to uses for the same, including use for a vaccine, for raising an immune response, for treatment of a disease and for diagnosis of a disease. The microparticles comprise a biodegradable polymer, such as a poly(α-hydroxy acid), a polyhydroxy butyric acid, a polycaprolactone, a polyorthoester, a polyanhydride, or a polycyanoacrylate, and a detergent selected from a cationic detergent and an anionic detergent. The microparticles further comprise an antigen adsorbed on the surface of the microparticle.

An endovascular cellular manipulation and inflammatory response are elicited from implantation in a vascular compartment or any intraluminal location of a separable coil comprised at least in part of at least one biocompatible and absorbable polymer or protein and growth factors. Typically a catheter associated with the separable coil is used to dispose the coil into a selected body lumen. The biocompatible and absorbable polymer or protein is thrombogenic. The coil further is comprised at least in part of a growth factor or more particularly a vascular endothelial growth factor, a basic fibroblast growth factor or other growth factors. The biocompatible and absorbable polymer is in the illustrated embodiment at least one polymer selected from the group consisting of polyglycolic acid, poly~glycolic acid poly-L-lactic acid copolymers, polycaprolactive, polyhydroxybutyrate / hydroxyvalerate copolymers, poly-L-lactide. Polydioxanone, polycarbonates, and polyanhydrides. The biocompatible and absorbable protein is at least one protein selected from the group consisting of collagen, fibrinogen, fibronectin, vitronectin, laminin, and gelatin. In one embodiment the coil is composed of the biocompatible and absorbable polymer or protein with a radio-opaque material is disposed thereon. Alternatively, the coil is composed of a radio-opaque material, and the biocompatible and absorbable polymer or protein is disposed thereon. This apparatus may be positioned within intracranial aneurysms or any aneurysm in the body as well as within other body cavities.

Polymers with improved bioadhesive properties and methods for improving bioadhesion of polymers have been developed. A compound containing an aromatic group which contains one or more hydroxyl groups is grafted onto a polymer or coupled to individual monomers. In one embodiment, the polymer is a biodegradable polymer. In another embodiment, the monomers may be polymerized to form any type of polymer, including biodegradable and non-biodegradable polymers. In some embodiments, the polymer is a hydrophobic polymer. In the preferred embodiment, the aromatic compound is catechol or a derivative thereof and the polymer contains reactive functional groups. In the most preferred embodiment, the polymer is a polyanhydride and the aromatic compound is the catechol derivative, DOPA. These materials display bioadhesive properties superior to conventional bioadhesives used in therapeutic and diagnostic applications. These bioadhesive materials can be used to fabricate new drug delivery or diagnostic systems with increased residence time at tissue surfaces, and consequently increase the bioavailability of a drug or a diagnostic agent. In a preferred embodiment, the bioadhesive material is a coating on a controlled release oral dosage formulation and / or forms a matrix in an oral dosage formulation.

a biocompatible and biodegradable implant for a cavity in a bone of a living organism is made of a biocompatible and biodegradable granules which are selected from the group including biopolymers, bioglasses, bioceramics preferably calcium sulfate, calcium phosphate such as monocalcium phosphate monohydrate, monocalcium phosphate anhydrous, dicalcium phosphate dihydrate, dicalcium phosphate anhydrous, tetracalcium phosphate, calcium orthophosphate phosphate, α-tricalcium phosphate, β-tricalcium phosphate, apatite such as hydroxyapatite, or a mixture thereof. The biocompatible and biodegradable granules are provided with a coating, which comprises at least one layer of a biocompatible and biodegradable polymer which is selected from the group including poly((α-hydroxyesters), poly(orthoesters), polyanhydrides, poly(phosphazenes), poly(propylene fumarate), poly(ester amides), poly(ethylene fumarate), polylactide, polyglycolide, polycaprolactone, poly(glycolide-co-trimethylene carbonate), polydioxanone, co-polymers thereof and blends of those polymers. The biocompatible and biodegradable implants are obtained by fusing together the polymer-coated granules through polymer-linkage of the polymer coatings of neighboring granules.

Polyanhydrides which link low molecular weight drugs containing a carboxylic acid group and an amine, thiol, alcohol, or phenol group within their structure into polymeric drug delivery systems are provided. Also provided are methods of producing polymeric drug delivery systems via these polyanhydride linkers as well as methods of administering low molecular weight drug to a host via the polymeric drug delivery systems. Medical implants based on the polymeric drug delivery system of the invention are also provided.

A new embolic agent, bioabsorbable polymeric material (BPM) is incorporated to a Guglielmi detachable coil (GDC) to improve long-term anatomic results in the endovascular treatment of intracranial aneurysms. The embolic agent, comprised at least in part of at least one biocompatible and bioabsorbable polymer and growth factors, is carried by hybrid bioactive coils and is used to accelerate histopathologic transformation of unorganized clot into fibrous connective tissue in experimental aneurysms. An endovascular cellular manipulation and inflammatory response are elicited from implantation in a vascular compartment or any intraluminal location. Thrombogenicity of the biocompatible and bioabsorbable polymer is controlled by the composition of the polymer. The coil further is comprised at least in part of a growth factor or more particularly a vascular endothelial growth factor, a basic fibroblast growth factor or other growth factors. The biocompatible and bioabsorbable polymer is in the illustrated embodiment at least one polymer selected from the group consisting of polyglycolic acid, poly~glycolic acid / poly-L-lactic acid copolymers, polycaprolactive, polyhydroxybutyrate / hydroxyvalerate copolymers, poly-L-lactide. Polydioxanone, polycarbonates, and polyanhydrides.

An aromatic polyanhydride having a repeating unit with structure (I) wherein Ar is a substituted or unsubstituted aromatic ring and R is a difunctional organic moiety substituted on each Ar ortho to the anhydride group. Ortho-substituted bis-aromatic dicarboxylic acid anhydride monomers and ortho-substituted bis-aromatic dicarboxylic acid intermediates thereof are also disclosed, as well as implantable medical devices, such as scaffolding implants for tissue reconstruction, drug delivery systems prepared from the aromatic polyanhydrides, as well as therapeutic oral dosage forms and treatment methods.

Embodiments of the invention include a method for treating an aneurysm, comprising: providing a biocompatible polymeric sleeve, string or coil or combination of sleeve, string or coil, made from a material selected from one or more of a group consisting of an acrylamide, a methacrylate, cyclodextran, synthetic elastin polymer, poly chelating amphiphilic polymers, hydrogels, hyaluronic acid conjugates, polyanhydrides, glycolipids, polysaccharides, and halamines, natural hydrogel, a synthetic hydrogel, silicone, polyurethane, polysulfone, cellulose, polyethylene, polypropylene, polyamide, polyimide, polyester, polytetrafluoroethylene, polyvinyl chloride, epoxy, phenolic, neoprene, polyisoprene, and a combination thereof; transporting the sleeve, string or coil to an aneurysm; filling the aneurysm with the sleeve, coil, or string; and detaching the sleeve, string or coil

A semi-synthetic platelet gel comprising a platelet-rich plasma, at least one platelet activator, and a biocompatible polymer selected from the group comprising carbomers, polyalkylene glycols, poloxamers, polyesters, polyethers, polyanhydrides, polyacrylates, polyvinyl acetates, polyvinyl pyrrolidones, polysaccharides, and derivatives thereof. A method for preparing a semi-synthetic platelet gel comprising the steps of (a) mixing a platelet-rich plasma with at least one platelet activator, and, before the start of clot formation, (b) adding the mixture thus obtained to a biocompatible polymer selected from the group comprising carbomers, polyalkylene glycols, poloxamers, polyesters, polyethers, polyanhydrides, polyacrylates, polyvinyl acetates, polyvinyl pyrrolidones, polysaccharides, and derivatives thereof.

Microparticles with adsorbent surfaces, methods of making such microparticles, and uses thereof, are disclosed. The microparticles comprise a polymer, such as a poly(α-hydroxy acid), a polyhydroxy butyric acid, a polycaprolactone, a polyorthoester, a polyanhydride, and the like, and are formed using cationic, anionic, or nonionic detergents. The surface of the microparticles efficiently adsorb biologically active macromolecules, such as DNA, polypeptides, antigens, and adjuvants. Also provided are compositions of an oil droplet emulsion having a metabolizable oil and an emulsifying agent. Immunogenic compositions having an immunostimulating amount of an antigenic substance, and an immunostimulating amount of an adjuvant composition are also provided. Methods of stimulating an immune response, methods of immunizing a host animal against a viral, bacterial, or parasitic infection, and methods of increasing a Th1 immune response in a host animal by administering to the animal an immunogenic composition of the microparticles, and / or microemulsions of the invention, are also provided.

The invention discloses a fiber-reinforced epoxy asphalt material and a preparation method thereof, belonging to the technical field of chemical new materials for roads and bridges. The fiber-reinforced epoxy asphalt material consists of a part A and a part B, wherein the part A consists of the following components in parts by mass: 40-100 parts of asphalt, 0.1-20 parts of fibers, 5-50 parts of methyl tetrahydrophthalic anhydride, 10-100 parts of dicarboxylic acid, 10-100 parts of dicarboxylic acid polyanhydride and 0.1-1.0 part of an epoxy resin curing accelerant; the part B is an epoxy resin; and the mass ratio of the part A to the part B is (1-5):1. Special equipment is not required during preparation, an operation process is simple, and environment friendliness is realized; and after the material is cured, a three-dimensional interpenetrating polymer network structure (I PN structure) with 'low overall crosslinking density and high local crosslinking density' is formed, so that the material has excellent high-temperature use strength, high deformation capability and extremely high low temperature toughness, and can be applied as a paved layer on large-span steel bridge surfaces and road surfaces in highly-cold climate regions.

Polymers containing one or more crylene and fluorene moieties attached to the polymer backbone, sunscreen compositions including a mixture of a photoactive compound and a polymer containing one or more crylene and fluorene moieties attached to the polymer backbone are described herein. Also disclosed are methods for stabilizing a sunscreen composition and methods of filtering out ultra-violet light from a substrate by the addition of one or more of the foregoing polymers, and methods of waterproofing and forming a film with one or more of the foregoing polymer are described herein.

A filtered smoking article is provided, which includes a tobacco-containing rod surrounded by a wrapping material; a filter element surrounded by a plug wrap adjacent to the tobacco-containing rod; and a tipping material securing the tobacco-containing rod to the filter element, the tipping material overlying the plug wrap of the filter element and a portion of the wrapping material of the tobacco-containing rod, wherein at least one of the plug wrap, the tipping material, and the wrapping material surrounding the tobacco-containing rod are secured by an adhesive composition comprising a thermoplastic starch polymer. The adhesive composition can include a blend of the thermoplastic starch polymer with a second biodegradable polymer, such as polyvinyl alcohol, aliphatic polyesters, aliphatic polyurethanes, cis-polyisoprene, cis-polybutadiene, polyhydroxy alkanoates, polyanhydrides, and copolymers and blends thereof.

The invention provides a high temperature-resistant epoxy resin composition for pultrusion and a preparation method. The high temperature-resistant epoxy resin composition for pultrusion comprises A and B components, wherein the A component comprises glycidyl ether epoxy resin, cycloaliphatic epoxy resin and an epoxy resin active diluents, the B component comprises cycloaliphatic anhydride, aromatic hydrocarbon polyanhydride, a thermoplastic phenolic resin curing agent, a maleic anhydride grafted rubber toughening agent, a polysiloxane toughening modifier, and an epoxy resin curing accelerator, and the ratio of the A component to the B component, by weight of the components, is 100:50-250. The composition of the invention has excellent high temperature resistance, and also maintains balance between processing properties, impact toughness and comprehensive performance. The prepared products can be used for a long time in rigorous wild high temperature environment.

Microparticles with adsorbent surfaces, methods of making such microparticles, and uses thereof, are disclosed. The microparticles comprise a polymer, such as a poly(α-hydroxy acid), a polyhydroxy butyric acid, a polycaprolactone, a polyorthoester, a polyanhydride, and the like, and are formed using cationic, anionic, or nonionic detergents. The surface of the microparticles efficiently adsorb biologically active macromolecules, such as DNA, polypeptides, antigens, and adjuvants. Also provided are compositions of an oil droplet emulsion having a metabolizable oil and an emulsifying agent. Immunogenic compositions having an immunostimulating amount of an antigenic substance, and an immunostimulating amount of an adjuvant composition are also provided. Methods of stimulating an immune response, methods of immunizing a host animal against a viral, bacterial, or parasitic infection, and methods of increasing a Th1 immune response in a host animal by administering to the animal an immunogenic composition of the microparticles, and / or microemulsions of the invention, are also provided.

Polymers (i.e. polyesters, polyamides, polythioesters, polyanhydrides, or a mixture thereof) which degrade hydrolytically to provide a combination of a beta-lactam antibiotic (e.g., amoxicillin) and a beta-lactamase inhibitor (e.g., clavulanic acid) (or a pharmaceutically acceptable salt thereof) are provided. Methods of producing these polymers, intermediates useful for preparing these polymers, and methods of using these polymers to deliver a combination of a beta-lactam antibiotic and a beta-lactamase inhibitor (or a pharmaceutically acceptable salt thereof) to a host are also provided.

The invention provides an epoxy asphalt material comprising a part A and a part B, wherein the part A comprises the following components in parts by weight: 100 parts of asphalt, 5-50 parts of epoxy diluent, 10-50 parts of epoxy compatibilizer, 10-50 parts of aliphatic dicarboxylic acid, 10-50 parts of aliphatic dicarboxylic acid polyanhydride and 5-50 parts of epoxy resin curing agent; the part B is epoxy resin; and the mass ratio of the part A to the part B is (0.5-5):1. In the invention, the epoxy diluent enables the obtained epoxy asphalt material to have good construction mobility at room temperature so that the epoxy asphalt material does not need to be heated for use and preserved with heat for transportation; and the epoxy asphalt material can be blended with stone at the room temperature for use, and has long operable time. Experimental results indicate that the epoxy asphalt material provided by the invention has a viscosity of about 200 cp at 20 DEG C and the time for the viscosity to reach 1000 cp is 84 minutes.

Polyanhydrides which link low molecular weight drugs containing a carboxylic acid group and an amine, thiol, alcohol or phenol group within their structure into polymeric drug delivery systems are provided. Also provided are methods of producing polymeric drug delivery systems via these polyanhydride linkers as well as methods of administering low molecular weight drugs to a host via the polymeric drug delivery systems.

A therapeutic compound consisting of human telomerase, its catalytic subunit hTert, or a known variant of either, and a biodegradable nanoparticle carrier, which can be administered to cells in a cell culture or in a living animal, is provided herein. The therapeutic compound is envisioned as a method for treating a wide variety of age-related diseases such as idiopathic pulmonary fibrosis, aplastic anemia, dyskeratosis congenita, arteriosclerosis, macular degeneration, osteoporosis, Alzheimer's, diabetes type 2, and any disease that correlates with telomere shortening and may be corrected or ameliorated by lengthening telomeres. The therapeutic compound is also envisioned as method for potentially treating more generic problems of human aging. The nanoparticle carrier is comprised of certain biodegradable biocompatible polymers such as poly(lactide-co-glycolide), poly(lactic acid), poly(alkylene glycol), polybutylcyanoacrylate, poly(methylmethacrylate-co-methacrylic acid), poly-allylamine, polyanhydride, polyhydroxybutyric acid, polycaprolactone, lactide-caprolactone copolymers, polyhydroxybutyrate, polyalkylcyanoacrylates, polyanhydrides, polyorthoester or a combination thereof. The nanoparticle may incorporate a targeting moiety to direct the nanoparticle to a particular tissue type or a location within a cell. The nanoparticle may incorporate a plasticizer to facilitate sustained release of telomerase such as L-tartaric acid dimethyl ester, triethyl citrate, or glyceryl triacetate. A nanoparticle of the present invention can further contain a polymer that affects the charge or lipophilicity or hydrophilicity of the particle. Any biocompatible hydrophilic polymer can be used for this purpose, including but not limited to, poly(vinyl alcohol).

A new embolic agent, bioabsorbable polymeric material (BPM) is incorporated to a Guglielmi detachable coil (GDC) to improve long-term anatomic results in the endovascular treatment of intracranial aneurysms. The embolic agent, comprised at least in part of at least one biocompatible and bioabsorbable polymer and growth factors, is carried by hybrid bioactive coils and is used to accelerate histopathologic transformation of unorganized clot into fibrous connective tissue in experimental aneurysms. An endovascular cellular manipulation and inflammatory response are elicited from implantation in a vascular compartment or any intraluminal location. Thrombogenicity of the biocompatible and bioabsorbable polymer is controlled by the composition of the polymer. The coil further is comprised at least in part of a growth factor or more particularly a vascular endothelial growth factor, a basic fibroblast growth factor or other growth factors. The biocompatible and bioabsorbable polymer is in the illustrated embodiment at least one polymer selected from the group consisting of polyglycolic acid, poly˜glycolic acid / poly-L-lactic acid copolymers, polycaprolactive, polyhydroxybutyrate / hydroxyvalerate copolymers, poly-L-lactide. Polydioxanone, polycarbonates, and polyanhydrides.

The present invention provides a method for forming compounds of Formula HO—C(═O)R1—X—R2—X—R1—C(═O)—O—H wherein compound (I) can be polymerized to provide a polymer that contains therapeutically active compounds. In the compounds of the invention, each R1 is group that will provide the therapeutically active compound upon hydrolysis of the polymer; each X is independently an ester linkage or an amide linkage; and R2 is a linking group.

The invention discloses a water-resistant wood-plastic composite material, which is prepared from the following raw materials in percentage by weight: 1-65% modified wood powder, 25-98% of polyolefin matrix and 1-10% compatilizer; wherein, the compatilizer is one of polysebacic polyanhydride (PSPA) and polyazelaic polyanhydride (PAPA) or both the two. The invention also discloses a preparation method of the water-resistant wood-plastic composite material. The method is as follows: PSPA and / or PAPA are / is utilized to carry out segmented surface grafting on the wood powder to improve the interface compatibility between the wood powder and polyethylene, and the wood powder is pretreated by alkali liquor to removing unstable substances, such as semi-cellulose and esters with small molecules, in the wood powder, thus enhancing the composite effect and the mechanical property of lignocellulose to the polyolefin matrix and obtaining the wood-plastic composite material with excellent mechanical property, low water absorption capacity and good dimensional stability; in addition, the operation of the preparation method is simple, and the method is applicable to industrial production.

Improved binder technology for use with fibrous materials is provided whereby the adjoining fibers of a fibrous material are bound in the absence of a phenol-formaldehyde reaction product. A curable binder composition is provided which comprises a water-soluble polyamic acid and an organic crosslinking agent capable of undergoing a covalent crosslinking reaction with the polyamic acid. The polyamic acid is formed by the reaction of a polycarboxylic acid and / or polyanhydride having a molecular weight of at least 150 with ammonia and / or amine compound. The binding composition is coated on a fibrous material and is heated to achieve crosslinking of the polyamic acid to form a cured water-resistant binder in association with the fibrous material wherein adjoining fibers are bound at cross-over points.

The invention belongs to the technical field of nano materials and particularly relates to a method for preparing a carbon nanofiber and carbon nanotube modified carbon fiber / epoxy resin multi-dimensional hybrid composite. The method comprises the following steps of: performing surface carboxylation and acylation treatment on carbon nanotubes, carbon nanofibers and carbob fibers; introducing diamine or polyamine to the obtained product; modifying amino carbon nanofibers and carbon nanotubes with an aromatic polyanhydride compound to prepare the carbon fibers, the carbon nanofibers and the carbon nanotubes carrying anhydride radicals; and ultrasonically oscillating the carbon nanofibers, the carbon nanotubes and the epoxy resin with the anhydride and stirring the mixed materials at a high speed to make the carbon nanofibers and the carbon nanotubes uniformly dispersed in the epoxy resin matrix and make the carbon nanofibers and the carbon nanotubes grafted with the anhydride and the epoxy resin fully undergo a chemical crosslinking reaction so as to obtain an epoxy resin linear block polymer, and combining the epoxy resin linear block polymer serving as a matrix and the carbon fibers to form multi-dimensional hybrid composite structures connected by covalent bonds. In the invention, by using the carbon nanotubes, the carbon nanofibers and the strength and toughness toughened epoxy resin, the bonding strength of carbon fiber interfaces is improved, so that the integral performance of the carbon fiber / epoxy resin multi-dimensional hybrid composite is improved, and the application range of the carbon fibers and the epoxy resin is widened.